YANTAI DONGCHENG PHARMACEUTICAL GROUP CO.,LTD.

Andere talen Yantai Dongcheng Pharmaceutical Group Co.,Ltd.

Aandelen

002675

CNE100001DP5

slotkoers Shenzhen S.E. Andere beurzen 00:00:00 26-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
13,31 ^CNY	+1,22%		+7,69%	-27,39%

26/04	Yantai Dongcheng Pharmaceutical Group Co.,Ltd. Rapporteert winstresultaten voor het volledige jaar eindigend op 31 december 2023	CI
11/04	Dongcheng Biochemicals' eenheid krijgt toestemming om tumormedicijn in Singapore te testen	MT

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Yantai Dongcheng Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	26/04
Dongcheng Biochemicals' Unit Gets Nod to Trial Tumor Drug in Singapore	11/04
Dongcheng Pharmaceutical to Buy Liver Drug Rights from Affiliate for 85 Million Yuan	21/02
Dongcheng Pharmaceutical Unit to Buy Rights to Tumor-Detecting Drug for 63 Million Yuan; Shares Up 10%	06/02
Dongcheng Pharma's Singaporean Unit Gets FDA's Nod to Carry Out Trial on 68GaLNC1007 Injection	29/01
Yantai Dongcheng Pharma Unit Secures License for Radioactive Cargo Transport	28/12
Dongcheng Pharmaceutical Gets Nod to Trial Tumor Drug in China	05/12
Yantai Dongcheng Pharmaceutical's Unit Ties Up With Chinese Physics Institute for Electron Accelerator Development	23/11
Yantai Dongcheng Pharma Gets Nod to Trial Prostate Cancer Treatment in China	21/11
Dongcheng Pharma Forms Medical Isotopes JV With Germany’s Eckert & Ziegler	15/11
Qi Kang Medical Technology Co., Ltd. announced that it has received ?20 million in funding from Yantai Dongcheng Pharmaceutical Group Co.,Ltd.	14/11
Dongcheng Biochemicals Unit Gets Nod to Trial Prostate Cancer Drug in Singapore	10/11
Dongcheng Biochemicals' Unit Gets Nod to Market Dalteparin Sodium Injection	01/11
Yantai Dongcheng Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	26-10-23
Dongcheng Biochemicals Receives Good Manufacturing Practice Certificate from Germany	18-10-23
Yantai Dongcheng Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-23
Yantai Dongcheng Pharma Registers Raw Material For Deep Vein Thrombosis Drug	01-08-23
Yantai Dongcheng Pharma Registers Deep Vein Thrombosis Drug	13-07-23
Yantai Dongcheng Pharmaceutical Group Co.,Ltd. Announces 2022 Final Profit Distribution Plan to Be Implemented (A Shares), Payment Date of 10 July 2023	03-07-23
Dongcheng Pharma Unit Gets Production License for Two Production Centers	27-06-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Yantai Dongcheng Pharmaceutical Group Co.,Ltd.

Aandelen

002675

CNE100001DP5

Andere talen

Filters